Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Zinc supplementation during in vitro embryo culture increases inner cell mass and total cell numbers in bovine blastocysts1.

Wooldridge LK, Nardi ME, Ealy AD.

J Anim Sci. 2019 Dec 17;97(12):4946-4950. doi: 10.1093/jas/skz351.

PMID:
31712807
2.

Interleukin-6 requires JAK to stimulate inner cell mass expansion in bovine embryos.

Wooldridge LK, Johnson SE, Cockrum RR, Ealy AD.

Reproduction. 2019 Aug 1. pii: REP-19-0286.R1. doi: 10.1530/REP-19-0286. [Epub ahead of print]

PMID:
31408846
3.

An assay of drug-induced emesis in the squirrel monkey (Saimiri sciureus).

Wooldridge LM, Kangas BD.

J Med Primatol. 2019 Aug;48(4):236-243. doi: 10.1111/jmp.12411. Epub 2019 Apr 10.

PMID:
30968960
4.

BOARD INVITED REVIEW: Post-transfer consequences of in vitro-produced embryos in cattle.

Ealy AD, Wooldridge LK, McCoski SR.

J Anim Sci. 2019 May 30;97(6):2555-2568. doi: 10.1093/jas/skz116. Review.

PMID:
30968113
5.

Interleukin-6 increases inner cell mass numbers in bovine embryos.

Wooldridge LK, Ealy AD.

BMC Dev Biol. 2019 Feb 1;19(1):2. doi: 10.1186/s12861-019-0182-z.

6.

Post-transfer outcomes in cultured bovine embryos supplemented with epidermal growth factor, fibroblast growth factor 2, and insulin-like growth factor 1.

Vailes MT, McCoski SR, Wooldridge LK, Reese ST, Pohler KG, Roper DA, Mercadante VR, Ealy AD.

Theriogenology. 2019 Jan 15;124:1-8. doi: 10.1016/j.theriogenology.2018.09.023. Epub 2018 Sep 24.

PMID:
30317067
7.

Agriculture in Shifting Climates: The Configuration and Ripeness of Problem Understandings in Uganda and Senegal.

Raile ED, Young LM, Bonabana-Wabbi J, Kirinya J, Mbaye S, Wooldridge L, Raile ANW, Post LA.

Rev Policy Res. 2018 Mar;35(2):302-325. doi: 10.1111/ropr.12284. Epub 2018 Feb 7.

8.

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

Bijen HM, van der Steen DM, Hagedoorn RS, Wouters AK, Wooldridge L, Falkenburg JHF, Heemskerk MHM.

Mol Ther. 2018 May 2;26(5):1206-1214. doi: 10.1016/j.ymthe.2018.02.017. Epub 2018 Feb 23.

9.

Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions.

Lissina A, McLaren JE, Ilander M, Andersson EI, Lewis CS, Clement M, Herman A, Ladell K, Llewellyn-Lacey S, Miners KL, Gostick E, Melenhorst JJ, Barrett AJ, Price DA, Mustjoki S, Wooldridge L.

Sci Rep. 2018 Feb 7;8(1):2534. doi: 10.1038/s41598-017-18062-x.

10.

The evolution of interferon-tau.

Ealy AD, Wooldridge LK.

Reproduction. 2017 Nov;154(5):F1-F10. doi: 10.1530/REP-17-0292. Review.

PMID:
28982935
11.

A new electron-ion coincidence 3D momentum-imaging method and its application in probing strong field dynamics of 2-phenylethyl-N, N-dimethylamine.

Fan L, Lee SK, Tu YJ, Mignolet B, Couch D, Dorney K, Nguyen Q, Wooldridge L, Murnane M, Remacle F, Bernhard Schlegel H, Li W.

J Chem Phys. 2017 Jul 7;147(1):013920. doi: 10.1063/1.4981526.

PMID:
28688410
12.

Tabletop Femtosecond VUV Photoionization and PEPICO Detection of Microreactor Pyrolysis Products.

Couch DE, Buckingham GT, Baraban JH, Porterfield JP, Wooldridge LA, Ellison GB, Kapteyn HC, Murnane MM, Peters WK.

J Phys Chem A. 2017 Jul 20;121(28):5280-5289. doi: 10.1021/acs.jpca.7b02821. Epub 2017 Jul 10.

PMID:
28661692
13.

Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.

Cole DK, van den Berg HA, Lloyd A, Crowther MD, Beck K, Ekeruche-Makinde J, Miles JJ, Bulek AM, Dolton G, Schauenburg AJ, Wall A, Fuller A, Clement M, Laugel B, Rizkallah PJ, Wooldridge L, Sewell AK.

J Biol Chem. 2017 Jan 20;292(3):802-813. doi: 10.1074/jbc.M116.741603. Epub 2016 Nov 30.

14.

Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies.

Clement M, Pearson JA, Gras S, van den Berg HA, Lissina A, Llewellyn-Lacey S, Willis MD, Dockree T, McLaren JE, Ekeruche-Makinde J, Gostick E, Robertson NP, Rossjohn J, Burrows SR, Price DA, Wong FS, Peakman M, Skowera A, Wooldridge L.

Sci Rep. 2016 Oct 17;6:35332. doi: 10.1038/srep35332.

15.

CD8+ T-cell specificity is compromised at a defined MHCI/CD8 affinity threshold.

Dockree T, Holland CJ, Clement M, Ladell K, McLaren JE, van den Berg HA, Gostick E, L Miners K, Llewellyn-Lacey S, Bridgeman JS, Man S, Bailey M, Burrows SR, Price DA, Wooldridge L.

Immunol Cell Biol. 2017 Jan;95(1):68-76. doi: 10.1038/icb.2016.85. Epub 2016 Nov 8.

16.

Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.

Grant EJ, Josephs TM, Valkenburg SA, Wooldridge L, Hellard M, Rossjohn J, Bharadwaj M, Kedzierska K, Gras S.

J Biol Chem. 2016 Nov 18;291(47):24335-24351. Epub 2016 Sep 19.

17.

Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.

Cole DK, Bulek AM, Dolton G, Schauenberg AJ, Szomolay B, Rittase W, Trimby A, Jothikumar P, Fuller A, Skowera A, Rossjohn J, Zhu C, Miles JJ, Peakman M, Wooldridge L, Rizkallah PJ, Sewell AK.

J Clin Invest. 2016 Sep 1;126(9):3626. doi: 10.1172/JCI89919. Epub 2016 Aug 15. No abstract available.

18.

Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.

Cole DK, Bulek AM, Dolton G, Schauenberg AJ, Szomolay B, Rittase W, Trimby A, Jothikumar P, Fuller A, Skowera A, Rossjohn J, Zhu C, Miles JJ, Peakman M, Wooldridge L, Rizkallah PJ, Sewell AK.

J Clin Invest. 2016 Jun 1;126(6):2191-204. doi: 10.1172/JCI85679. Epub 2016 May 16. Erratum in: J Clin Invest. 2016 Sep 1;126(9):3626.

19.

Letters to the Editor.

Wooldridge LS.

Urol Nurs. 2016 Jan-Feb;36(1):45-6. No abstract available.

PMID:
27093764
20.

Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors.

Szomolay B, Liu J, Brown PE, Miles JJ, Clement M, Llewellyn-Lacey S, Dolton G, Ekeruche-Makinde J, Lissina A, Schauenburg AJ, Sewell AK, Burrows SR, Roederer M, Price DA, Wooldridge L, van den Berg HA.

Immunol Cell Biol. 2016 Jul;94(6):573-82. doi: 10.1038/icb.2016.12. Epub 2016 Feb 5.

21.

Clinical research: developing an appropriate career structure.

Mellanby RJ, Price J, Wooldridge L, Jonsson NN, Clegg PD, Emes RD, England G, Corr SA, Piercy RJ, Mulcahy G, Wood JL, Walker BR, Argyle DJ.

Vet Rec. 2015 Nov 28;177(21):544-7. doi: 10.1136/vr.h6169. No abstract available.

22.

Naive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamics.

Neller MA, Ladell K, McLaren JE, Matthews KK, Gostick E, Pentier JM, Dolton G, Schauenburg AJ, Koning D, Fontaine Costa AI, Watkins TS, Venturi V, Smith C, Khanna R, Miners K, Clement M, Wooldridge L, Cole DK, van Baarle D, Sewell AK, Burrows SR, Price DA, Miles JJ.

Immunol Cell Biol. 2015 Aug;93(7):625-33. doi: 10.1038/icb.2015.17. Epub 2015 Mar 24.

23.

Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Hill BJ, Darrah PA, Ende Z, Ambrozak DR, Quinn KM, Darko S, Gostick E, Wooldridge L, van den Berg HA, Venturi V, Larsen M, Davenport MP, Seder RA, Price DA, Douek DC.

J Immunol. 2014 Dec 1;193(11):5626-36. doi: 10.4049/jimmunol.1401017. Epub 2014 Oct 27.

24.

Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy.

Szomolay B, Williams T, Wooldridge L, van den Berg HA.

Front Immunol. 2013 Oct 21;4:329. doi: 10.3389/fimmu.2013.00329. Review. Erratum in: Front Immunol. 2014;5:443.

25.

Cellular-level versus receptor-level response threshold hierarchies in T-cell activation.

van den Berg HA, Ladell K, Miners K, Laugel B, Llewellyn-Lacey S, Clement M, Cole DK, Gostick E, Wooldridge L, Sewell AK, Bridgeman JS, Price DA.

Front Immunol. 2013 Sep 5;4:250. doi: 10.3389/fimmu.2013.00250. eCollection 2013.

26.

Individual MHCI-Restricted T-Cell Receptors are Characterized by a Unique Peptide Recognition Signature.

Wooldridge L.

Front Immunol. 2013 Jul 23;4:199. doi: 10.3389/fimmu.2013.00199. eCollection 2013.

27.

The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses.

Xu W, Watts DM, Costanzo MC, Tang X, Venegas LA, Jiao F, Sette A, Sidney J, Sewell AK, Wooldridge L, Makino S, Morrill JC, Peters CJ, Kan-Mitchell J.

PLoS One. 2013;8(3):e59210. doi: 10.1371/journal.pone.0059210. Epub 2013 Mar 18.

28.

Peptide length determines the outcome of TCR/peptide-MHCI engagement.

Ekeruche-Makinde J, Miles JJ, van den Berg HA, Skowera A, Cole DK, Dolton G, Schauenburg AJ, Tan MP, Pentier JM, Llewellyn-Lacey S, Miles KM, Bulek AM, Clement M, Williams T, Trimby A, Bailey M, Rizkallah P, Rossjohn J, Peakman M, Price DA, Burrows SR, Sewell AK, Wooldridge L.

Blood. 2013 Feb 14;121(7):1112-23. doi: 10.1182/blood-2012-06-437202. Epub 2012 Dec 18.

29.

Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.

Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.

J Urol. 2013 Jun;189(6):2194-201. doi: 10.1016/j.juro.2012.11.175. Epub 2012 Dec 3.

PMID:
23219541
30.

Avidity of influenza-specific memory CD8+ T-cell populations decays over time compromising antiviral immunity.

Humphreys IR, Clement M, Marsden M, Ladell K, McLaren JE, Smart K, Hindley JP, Bridgeman HM, van den Berg HA, Price DA, Ager A, Wooldridge L, Godkin A, Gallimore AM.

Eur J Immunol. 2012 Dec;42(12):3235-42. doi: 10.1002/eji.201242575. Epub 2012 Oct 16.

31.

T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.

Ekeruche-Makinde J, Clement M, Cole DK, Edwards ES, Ladell K, Miles JJ, Matthews KK, Fuller A, Lloyd KA, Madura F, Dolton GM, Pentier J, Lissina A, Gostick E, Baxter TK, Baker BM, Rizkallah PJ, Price DA, Wooldridge L, Sewell AK.

J Biol Chem. 2012 Oct 26;287(44):37269-81. doi: 10.1074/jbc.M112.386409. Epub 2012 Sep 5.

32.

Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidity.

Knight RR, Kronenberg D, Zhao M, Huang GC, Eichmann M, Bulek A, Wooldridge L, Cole DK, Sewell AK, Peakman M, Skowera A.

Diabetes. 2013 Jan;62(1):205-13. doi: 10.2337/db12-0315. Epub 2012 Aug 30.

33.

Managing a pessary business.

O'Dell K, Wooldridge LS, Atnip S.

Urol Nurs. 2012 May-Jun;32(3):138-45; quiz 146. Review.

PMID:
22860392
34.

The molecular determinants of CD8 co-receptor function.

Cole DK, Laugel B, Clement M, Price DA, Wooldridge L, Sewell AK.

Immunology. 2012 Oct;137(2):139-48. doi: 10.1111/j.1365-2567.2012.03625.x. Review.

35.

Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.

Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, Franco N, Bennett JB.

Neurourol Urodyn. 2013 Jan;32(1):24-9. doi: 10.1002/nau.22266. Epub 2012 Jun 5.

PMID:
22674493
36.

Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.

Bulek AM, Cole DK, Skowera A, Dolton G, Gras S, Madura F, Fuller A, Miles JJ, Gostick E, Price DA, Drijfhout JW, Knight RR, Huang GC, Lissin N, Molloy PE, Wooldridge L, Jakobsen BK, Rossjohn J, Peakman M, Rizkallah PJ, Sewell AK.

Nat Immunol. 2012 Jan 15;13(3):283-9. doi: 10.1038/ni.2206.

37.

A single autoimmune T cell receptor recognizes more than a million different peptides.

Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, Dolton G, Clement M, Llewellyn-Lacey S, Price DA, Peakman M, Sewell AK.

J Biol Chem. 2012 Jan 6;287(2):1168-77. doi: 10.1074/jbc.M111.289488. Epub 2011 Nov 18.

38.

The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells.

Laugel B, Cole DK, Clement M, Wooldridge L, Price DA, Sewell AK.

J Leukoc Biol. 2011 Dec;90(6):1089-99. doi: 10.1189/jlb.0611316. Epub 2011 Sep 27. Review.

PMID:
21954283
39.

Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Iglesias MC, Almeida JR, Fastenackels S, van Bockel DJ, Hashimoto M, Venturi V, Gostick E, Urrutia A, Wooldridge L, Clement M, Gras S, Wilmann PG, Autran B, Moris A, Rossjohn J, Davenport MP, Takiguchi M, Brander C, Douek DC, Kelleher AD, Price DA, Appay V.

Blood. 2011 Aug 25;118(8):2138-49. doi: 10.1182/blood-2011-01-328781. Epub 2011 Jul 6.

40.

Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.

Clement M, Ladell K, Ekeruche-Makinde J, Miles JJ, Edwards ES, Dolton G, Williams T, Schauenburg AJ, Cole DK, Lauder SN, Gallimore AM, Godkin AJ, Burrows SR, Price DA, Sewell AK, Wooldridge L.

J Immunol. 2011 Jul 15;187(2):654-63. doi: 10.4049/jimmunol.1003941. Epub 2011 Jun 15.

41.

Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.

Miles JJ, Bulek AM, Cole DK, Gostick E, Schauenburg AJ, Dolton G, Venturi V, Davenport MP, Tan MP, Burrows SR, Wooldridge L, Price DA, Rizkallah PJ, Sewell AK.

PLoS Pathog. 2010 Nov 18;6(11):e1001198. doi: 10.1371/journal.ppat.1001198.

42.

CD8 controls T cell cross-reactivity.

Wooldridge L, Laugel B, Ekeruche J, Clement M, van den Berg HA, Price DA, Sewell AK.

J Immunol. 2010 Oct 15;185(8):4625-32. doi: 10.4049/jimmunol.1001480. Epub 2010 Sep 15.

43.

Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition.

Cole DK, Edwards ES, Wynn KK, Clement M, Miles JJ, Ladell K, Ekeruche J, Gostick E, Adams KJ, Skowera A, Peakman M, Wooldridge L, Price DA, Sewell AK.

J Immunol. 2010 Aug 15;185(4):2600-10. doi: 10.4049/jimmunol.1000629. Epub 2010 Jul 16.

44.

Promoting continence awareness and community education.

Wooldridge LS.

Ostomy Wound Manage. 2009 Dec 1;55(12):4. No abstract available.

45.

MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.

Wooldridge L, Clement M, Lissina A, Edwards ES, Ladell K, Ekeruche J, Hewitt RE, Laugel B, Gostick E, Cole DK, Debets R, Berrevoets C, Miles JJ, Burrows SR, Price DA, Sewell AK.

J Immunol. 2010 Apr 1;184(7):3357-66. doi: 10.4049/jimmunol.0902398. Epub 2010 Feb 26.

46.

Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.

Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, Macdiarmid SA.

J Urol. 2010 Apr;183(4):1438-43. doi: 10.1016/j.juro.2009.12.036. Epub 2010 Feb 20.

PMID:
20171677
47.

Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.

Chen JL, Morgan AJ, Stewart-Jones G, Shepherd D, Bossi G, Wooldridge L, Hutchinson SL, Sewell AK, Griffiths GM, van der Merwe PA, Jones EY, Galione A, Cerundolo V.

J Immunol. 2010 Feb 15;184(4):1829-1839. doi: 10.4049/jimmunol.0902103. Epub 2010 Jan 6.

48.

Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.

MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Siegel SW, Tate SB, Feagins BA.

J Urol. 2010 Jan;183(1):234-40. doi: 10.1016/j.juro.2009.08.160.

PMID:
19913821
49.

ELISPOT and functional T cell analyses using HLA mono-specific target cells.

Horlock C, Stott B, Dyson J, Ogg G, McPherson T, Jones L, Sewell AK, Wooldridge L, Cole DK, Stebbing J, Savage P.

J Immunol Methods. 2009 Oct 31;350(1-2):150-60. doi: 10.1016/j.jim.2009.08.011. Epub 2009 Sep 1.

PMID:
19729014
50.

Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.

Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.

J Urol. 2009 Sep;182(3):1055-61. doi: 10.1016/j.juro.2009.05.045. Epub 2009 Jul 18.

PMID:
19616802

Supplemental Content

Loading ...
Support Center